The role of preventive cardiology in systemic lupus erythematosus

Jennifer Rae Elliott1, Susan Manzi, Daniel Edmundowicz

  • 1University of Pittsburgh School of Medicine, S727 Biomedical Sciences Tower, 3500 Terrace Street, Pittsburgh, PA 15261, USA. elliottjr@upmc.edu

Insights

Systemic lupus erythematosus (SLE) patients face increased cardiovascular disease risk. Integrating preventive cardiology into SLE care is crucial for managing this leading cause of death.

Area of Science:

  • Rheumatology
  • Cardiology
  • Public Health

Background:

  • Cardiovascular disease (CVD) is a primary cause of mortality in systemic lupus erythematosus (SLE) patients.
  • Accelerated atherosclerosis in SLE is linked to traditional CVD risk factors, inflammation, and lupus-specific factors.
  • Current evaluation of CVD risk in SLE patients is insufficient despite known risks.

Purpose of the Study:

  • To highlight the significant cardiovascular risk in SLE patients.
  • To advocate for the integration of preventive cardiology into multidisciplinary SLE care.
  • To emphasize the need for expert cardiovascular risk assessment in SLE management.

Main Methods:

  • Review of current understanding of CVD in SLE.
  • Analysis of the interplay between traditional risk factors, inflammation, and SLE.
  • Proposal for enhanced patient care protocols.

Main Results:

  • Cardiovascular disease is a leading cause of death in SLE patients.
  • Premature atherosclerosis is a significant concern in this population.
  • Sub-optimal assessment of traditional cardiovascular risk factors exists.

Conclusions:

  • Preventive cardiologists should be integral to SLE patient care.
  • Enhanced cardiovascular risk evaluation is necessary for SLE patients.
  • Multidisciplinary care including preventive cardiology can improve outcomes for SLE patients.

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...